These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21144983)

  • 61. Principles of Anti-infective Dosing in Pregnancy.
    Patil AS; Sheng JS; Dotters-Katz SK; Schmoll MS; Onslow ML
    Clin Ther; 2016 Sep; 38(9):2006-15. PubMed ID: 27614913
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Therapeutic drug monitoring of antiinfectives in intensive care unit patients - what's new?].
    König C; Kluge S; Wicha SG
    Dtsch Med Wochenschr; 2020 Dec; 145(24):1764-1769. PubMed ID: 33254251
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Conference tackles overprescribing of antimicrobials.
    Traynor K
    Am J Health Syst Pharm; 2004 Aug; 61(16):1643, 1647-8. PubMed ID: 15540473
    [No Abstract]   [Full Text] [Related]  

  • 64. What can be expected from antimicrobial de-escalation in the critically ill?
    Kollef MH
    Intensive Care Med; 2014 Jan; 40(1):92-5. PubMed ID: 24248604
    [No Abstract]   [Full Text] [Related]  

  • 65. [PK/PD analysis and proper dosage of antimicrobial agents for effective and safe treatment of infectious diseases].
    Hori S
    Yakugaku Zasshi; 2007 Jun; 127(6):931-7. PubMed ID: 17541242
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy].
    Dworacka M; Nowocień T
    Pol Merkur Lekarski; 2017 Feb; 42(248):61-64. PubMed ID: 28258678
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Criteria for safety evaluation of antimicrobial agents.
    ; ; Watanabe A; Tokue Y; Aoki N; Matsumoto T; Yanagihara K; Higa F; Tsuge H; Nagashima M; Matsuoka H; Sasagawa Y; Matsumoto M; Fujimaki K; Taguchi K; Ariyasu M; Yamamoto N; Kunii O; Shiba K
    J Infect Chemother; 2011 Feb; 17(1):139-47. PubMed ID: 21207093
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment of Calves with Bovine Respiratory Disease: Duration of Therapy and Posttreatment Intervals.
    Apley MD
    Vet Clin North Am Food Anim Pract; 2015 Nov; 31(3):441-53, vii. PubMed ID: 26253265
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antimicrobial therapy for the elderly patient.
    Yoshikawa TT
    J Am Geriatr Soc; 1990 Dec; 38(12):1353-72. PubMed ID: 2254575
    [No Abstract]   [Full Text] [Related]  

  • 70. Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.
    Ortwine JK; Pogue JM; Faris J
    J Burn Care Res; 2015; 36(2):e72-84. PubMed ID: 25167375
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antimicrobial cycling: the future or a fad?
    Hodges BM; White RL
    Ann Pharmacother; 2001 Oct; 35(10):1224-32. PubMed ID: 11675852
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Remediable causes of failure of "appropriate" antimicrobial therapy.
    Sanders E; Jurgensen PF
    Postgrad Med; 1971 Nov; 50(5):161-5. PubMed ID: 5130349
    [No Abstract]   [Full Text] [Related]  

  • 73. Impact of sampling peritoneal fluid during emergency laparotomy on antimicrobial prescriptions in the ICU.
    Muschik S; Pye E; Goodwin C; Butler J; Georgiou A
    Br J Anaesth; 2021 Jul; 127(1):e19-e20. PubMed ID: 34024638
    [No Abstract]   [Full Text] [Related]  

  • 74. Rationalising dosage regimens of antimicrobial drugs: a pharmacological perspective.
    The Editors
    J Med Microbiol; 2000 Nov; 49(11):943-945. PubMed ID: 11073148
    [No Abstract]   [Full Text] [Related]  

  • 75. Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?
    Day T; Read AF
    PLoS Comput Biol; 2016 Jan; 12(1):e1004689. PubMed ID: 26820986
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antimicrobial Resistance--2006 Annual Conference. Science--prevention--control. 26-28 June 2006, Bethesda, MD, USA.
    Theuretzbacher U
    IDrugs; 2006 Sep; 9(9):622-4. PubMed ID: 16952068
    [No Abstract]   [Full Text] [Related]  

  • 77. Drug interactions in the intensive care unit.
    Romac DR; Albertson TE
    Clin Chest Med; 1999 Jun; 20(2):385-99, ix. PubMed ID: 10386263
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Concentration controlled and concentration defined clinical trials: do they offer any advantages for antimicrobial chemotherapy?
    MacGowan A
    J Antimicrob Chemother; 1996 Jan; 37(1):1-5. PubMed ID: 8647750
    [No Abstract]   [Full Text] [Related]  

  • 79. Short versus regular-course antimicrobial therapy for intraabdominal infections.
    Nasr ZG; Saad MO
    Int J Pharm Pract; 2017 Feb; 25(1):99. PubMed ID: 28097721
    [No Abstract]   [Full Text] [Related]  

  • 80. Ensuring quality pharmacokinetic analyses in antimicrobial drug development programs.
    Lakota EA; Bader JC; Rubino CM
    Curr Opin Pharmacol; 2017 Oct; 36():139-145. PubMed ID: 29156443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.